Kamyar Kalantar-Zadeh M.D. to Calcifediol
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Calcifediol.
Connection Strength
0.710
-
The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3-4 CKD. J Med Econ. 2020 Mar; 23(3):308-315.
Score: 0.660
-
REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients. Nutrition. 2023 03; 107:111899.
Score: 0.050